Search Results - "ANNALS OF SURGICAL ONCOLOGY"

GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists by Deo, S. V. S., Sharma, Jyoti, Kumar, Sunil

“…Cancer is emerging as a major public health challenge globally. Recently, IARC (International Association of Research on Cancer) published global cancer burden…”
Get full text

AJCC 8th Edition: Colorectal Cancer by Weiser, Martin R.

Get full text

8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers by Chun, Yun Shin, Pawlik, Timothy M., Vauthey, Jean-Nicolas

Get full text

Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer by Giuliano, Armando E., Edge, Stephen B., Hortobagyi, Gabriel N.

Get full text

Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma by Erstad, Derek J., Tanabe, Kenneth K.

“…Hepatocellular carcinoma (HCC) is a morbid condition for which surgical and ablative therapy are the only options for cure. Nonetheless, over half of patients…”
Get full text

Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012–2014 by Mallin, Katherine, Browner, Amanda, Palis, Bryan, Gay, Greer, McCabe, Ryan, Nogueira, Leticia, Yabroff, Robin, Shulman, Lawrence, Facktor, Matthew, Winchester, David P., Nelson, Heidi

“…Background The National Cancer Database (NCDB) is a hospital-based cancer registry that includes diagnostic, staging, treatment, and outcomes data for newly…”
Get full text

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond by Gershenwald, Jeffrey E., Scolyer, Richard A.

Get full text

Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01 by Soran, Atilla, Ozmen, Vahit, Ozbas, Serdar, Karanlik, Hasan, Muslumanoglu, Mahmut, Igci, Abdullah, Canturk, Zafer, Utkan, Zafer, Ozaslan, Cihangir, Evrensel, Turkkan, Uras, Cihan, Aksaz, Erol, Soyder, Aykut, Ugurlu, Umit, Col, Cavit, Cabioglu, Neslihan, Bozkurt, Betül, Uzunkoy, Ali, Koksal, Neset, Gulluoglu, Bahadir M., Unal, Bulent, Atalay, Can, Yıldırım, Emin, Erdem, Ergun, Salimoglu, Semra, Sezer, Atakan, Koyuncu, Ayhan, Gurleyik, Gunay, Alagol, Haluk, Ulufi, Nalan, Berberoglu, Uğur, Dulger, Mustafa, Cengiz, Omer, Sezgin, Efe, Johnson, Ronald

“…Background The MF07-01 trial is a multicenter, phase III, randomized, controlled study comparing locoregional treatment (LRT) followed by systemic therapy (ST)…”
Get full text

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group by Swallow, Carol J., Strauss, Dirk C., Bonvalot, Sylvie, Rutkowski, Piotr, Desai, Anant, Gladdy, Rebecca A., Gonzalez, Ricardo, Gyorki, David E., Fairweather, Mark, van Houdt, Winan J., Stoeckle, Eberhard, Park, Jae Berm, Albertsmeier, Markus, Nessim, Carolyn, Cardona, Kenneth, Fiore, Marco, Hayes, Andrew, Tzanis, Dimitri, Skoczylas, Jacek, Ford, Samuel J., Ng, Deanna, Mullinax, John E., Snow, Hayden, Haas, Rick L., Callegaro, Dario, Smith, Myles J., Bouhadiba, Toufik, Stacchiotti, Silvia, Jones, Robin L., DeLaney, Thomas, Roland, Christina L., Raut, Chandrajit P., Gronchi, Alessandro

“…Background Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare tumors of mesenchymal origin that include several well-defined…”
Get full text

Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations by Bartlett, David L., Howe, James R., Chang, George, Crago, Aimee, Hogg, Melissa, Karakousis, Giorgos, Levine, Edward, Maker, Ajay, Mamounas, Eleftherios, McGuire, Kandace, Merchant, Nipun, Shibata, David, Sohn, Vance, Solorzano, Carmen, Turaga, Kiran, White, Richard, Yang, Anthony, Yoon, Sam

Get full text

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons by Manahan, Eric R., Kuerer, Henry M., Sebastian, Molly, Hughes, Kevin S., Boughey, Judy C., Euhus, David M., Boolbol, Susan K., Taylor, Walton A.

“…Background The purpose of this consensus guideline is to outline recommendations for genetic testing that medical professionals can use to assess hereditary…”
Get full text

Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System by Harms, Kelly L., Healy, Mark A., Nghiem, Paul, Sober, Arthur J., Johnson, Timothy M., Bichakjian, Christopher K., Wong, Sandra L.

“…Background The first consensus Merkel cell carcinoma (MCC) staging system was published in 2010. New information on the clinical course prompts review of MCC…”
Get full text

Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database by In, Haejin, Solsky, I., Palis, B., Langdon-Embry, M., Ajani, J., Sano, T.

“…Background The 8th edition AJCC gastric cancer staging manual was refined using Japanese and Korean data from the International Gastric Cancer Association…”
Get full text

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis by Yodying, Hariruk, Matsuda, Akihisa, Miyashita, Masao, Matsumoto, Satoshi, Sakurazawa, Nobuyuki, Yamada, Marina, Uchida, Eiji

“…Background Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been reported to predict oncologic outcomes in patients with…”
Get full text

Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification by Tsilimigras, Diamantis I., Bagante, Fabio, Sahara, Kota, Moris, Dimitrios, Hyer, J. Madison, Wu, Lu, Ratti, Francesca, Marques, Hugo P., Soubrane, Olivier, Paredes, Anghela Z., Lam, Vincent, Poultsides, George A., Popescu, Irinel, Alexandrescu, Sorin, Martel, Guillaume, Workneh, Aklile, Guglielmi, Alfredo, Hugh, Tom, Aldrighetti, Luca, Endo, Itaru, Pawlik, Timothy M.

“…Background Although the Barcelona Clinic Liver Cancer (BCLC) staging system has been largely adopted in clinical practice, recent studies have questioned the…”
Get full text

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study by Mamtani, Anita, Barrio, Andrea V., King, Tari A., Van Zee, Kimberly J., Plitas, George, Pilewskie, Melissa, El-Tamer, Mahmoud, Gemignani, Mary L., Heerdt, Alexandra S., Sclafani, Lisa M., Sacchini, Virgilio, Cody, Hiram S., Patil, Sujata, Morrow, Monica

“…Background In breast cancer patients with nodal metastases at presentation, false-negative rates lower than 10 % have been demonstrated for sentinel node…”
Get full text

Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis by Fan, Yibo, Che, Xiaofang, Qu, Jinglei, Hou, Kezuo, Wen, Ti, Li, Zhi, Li, Ce, Wang, Shuo, Xu, Ling, Liu, Yunpeng, Qu, Xiujuan

“…Background A recent study showed that circulating exosomal PD-L1 is an effective predictor for anti-PD-1 therapy in melanomas. Exosomal PD-L1 induced…”
Get full text

TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG by Leong, Trevor, Smithers, B. Mark, Haustermans, Karin, Michael, Michael, Gebski, Val, Miller, Danielle, Zalcberg, John, Boussioutas, Alex, Findlay, Michael, O’Connell, Rachel L., Verghis, Jaclyn, Willis, David, Kron, Tomas, Crain, Melissa, Murray, William K., Lordick, Florian, Swallow, Carol, Darling, Gail, Simes, John, Wong, Rebecca

“…Background Postoperative chemoradiation and perioperative chemotherapy using epirubicin/cisplatin/5-fluorouracil (ECF) represent two standards of care for…”
Get full text

Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis by Kamarajah, Sivesh K., Burns, William R., Frankel, Timothy L., Cho, Clifford S., Nathan, Hari

“…Background The 8th edition of the AJCC staging system for pancreatic cancer incorporated several significant changes. This study sought to evaluate this…”
Get full text

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial by Andtbacka, Robert H. I., Ross, Merrick, Puzanov, Igor, Milhem, Mohammed, Collichio, Frances, Delman, Keith A., Amatruda, Thomas, Zager, Jonathan S., Cranmer, Lee, Hsueh, Eddy, Chen, Lisa, Shilkrut, Mark, Kaufman, Howard L.

“…Purpose Talimogene laherparepvec (T-VEC) is an oncolytic immunotherapy designed to induce tumor regression of injected lesions through direct lytic effects,…”
Get full text